Sumitomo Mitsui Trust Holdings, Inc. Moderna, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,446,717 shares of MRNA stock, worth $105 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,446,717
Previous 1,545,829
6.41%
Holding current value
$105 Million
Previous $165 Million
4.29%
% of portfolio
0.13%
Previous 0.11%
Shares
17 transactions
Others Institutions Holding MRNA
# of Institutions
1,112Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$3.17 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.88 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.86 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$1.1 Billion0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$527 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $28.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...